(Press-News.org) CINCINNATI – Researchers have overcome a major challenge to treating brain diseases by engineering an experimental molecular therapy that crosses the blood-brain barrier to reverse neurological lysosomal storage disease in mice.
Posted online in PNAS Early Edition on Feb. 4, the study was led by scientists at Cincinnati Children's Hospital Medical Center.
"This study provides a non-invasive procedure that targets the blood-brain barrier and delivers large-molecule therapeutic agents to treat neurological lysosomal storage disorders," said Dao Pan, PhD, principal investigator on the study and researcher in the Cancer and Blood Diseases Institute at Cincinnati Children's. "Our findings will allow the development of drugs that can be tested for other brain diseases like Parkinson's and Alzheimer's."
The scientists assembled the large molecular agents by merging part of a fatty protein called apolipoprotein E (apoE) with a therapeutic lysosomal enzyme called a-L-idurondase (IDUA). Naming the agents IDUAe1 and IDUAe2, researchers used them initially to treat laboratory cultured human cells of the disease mucopolysaccharidosis type I (MPS I). They also tested the agents on mouse models of MPS I.
MPS I is one of the most common lysosomal storage diseases to affect the central nervous system, which in severe form can become Hurler syndrome. In humans, patients can suffer from hydrocephalus, learning delays and other cognitive deficits. If not treated, many patients die by age 10.
Lysosomes are part of a cell's internal machinery, serving as a waste disposal system that helps rid cells of debris to retain normal function. In lysosomal storage diseases like MPS I, enzymes needed to dissolve debris are missing, allowing debris to build up in cells until they malfunction.
In MPS I, cells lack the IDUA enzyme, allowing abnormal accumulation of a group of large molecules called glycosaminoglycans in the brain and other organs. Researchers in the current study used the new therapeutic procedure to deliver IDUA to brain cells. But first they had to successfully engineer the therapy to carry IDUA through the blood-brain barrier to diseased brain cells.
The blood-brain barrier is a physiological blockade that alters the permeability of tiny blood vessels called capillaries in the brain. Its purpose is to protect the brain by preventing certain drugs, pathogens and other foreign substances from entering brain tissues. The barrier has also been a persistent roadblock to treating brain disease with drugs.
The scientists experimented with a set of derivative components of the fatty protein apoE, which binds to fat receptors on endothelial cells that form the inside surface of capillaries in the blood-brain barrier. They discovered that tagging some of the apoE components to the IDUA enzyme allowed the modified protein to attach to endothelial cells and cross through the cells to reach brain tissues.
Researchers injected experimental IDUAe1 into the tail veins of MPS I mouse models. The tests showed that – unlike currently available un-modified enzyme treatments – the modified enzyme penetrated the blood-brain barrier and entered brain neurons and astrocytes in a dose-dependent manner.
The researchers also reported that brain cells in the treated mice exhibited normalized levels of the glycosaminoglycans and the lysosomal enzyme beta-hexosaminidase. With continued treatment through hematopoietic stem cell gene therapy, normalized levels persisted until the end of a five-month observation period, researchers said.
The scientists are continuing their preclinical studies to further verify the use of the experimental IDUA-based agents for treating MPS I, cautioning that results in laboratory mice may face additional challenges when translating to clinical application in humans.
Researchers are also testing whether the large-molecule therapeutic procedure used in the current study can be leveraged to develop other neurotherapeutic agents that cross the blood-brain barrier.
Also collaborating on the study was Roscoe O. Brady, MD, a researcher and scientist emeritus at the National Institute of Neurological Disorders and Stroke.
###
Funding support for the study came from National Institutes of Health grants NS064330, DK074932 and U54 HL06-008.
About Cincinnati Children's:
Cincinnati Children's Hospital Medical Center ranks third in the nation among all Honor Roll hospitals in U.S. News and World Report's 2012 Best Children's Hospitals ranking. It is ranked #1 for neonatology and in the top 10 for all pediatric specialties. Cincinnati Children's is one of the top two recipients of pediatric research grants from the National Institutes of Health and a research affiliate of the University of Cincinnati College of Medicine. It is internationally recognized for improving child health and transforming delivery of care through fully integrated, globally recognized research, education and innovation. Additional information can be found at www.cincinnatichildrens.org. END
Experimental therapy crosses blood-brain barrier to treat neurological disease
2013-02-05
ELSE PRESS RELEASES FROM THIS DATE:
Body language can predict outcomes for recovering alcoholics
2013-02-05
To predict whether a problem drinker will hit the bottle again, ignore what they say and watch their body language for displays of shame, a University of British Columbia study finds.
The study, which explored drinking and health outcomes in newly sober recovering alcoholics, is the first to show that physical manifestations of shame – from slumped shoulders to narrow chests – can directly predict a relapse in people who struggle with substances.
"Our study finds that how much shame people display can strongly predict not only whether they will go on to relapse, but ...
20 hours of TV a week almost halves sperm count
2013-02-05
Healthy young men who watch TV for more than 20 hours a week have almost half the sperm count of men who watch very little TV, indicates a study published online in the British Journal of Sports Medicine.
Conversely, men who do 15 or more hours of moderate to vigorous exercise every week have sperm counts that are 73% higher than those who exercise little, the findings show.
Semen quality seems to have deteriorated over the past few decades, although it's not clear why, say the authors.
To find out if an increasingly sedentary lifestyle might be a contributory ...
The last Neanderthals of southern Iberia did not coexist with modern humans
2013-02-05
The theory that the last Neanderthals –Homo neanderthalensis– persisted in southern Iberia at the same time that modern humans –Homo sapiens– advanced in the northern part of the peninsula, has been widely accepted by the scientific community during the last twenty years. An international study, in which researchers of the Spanish National Distance Education University (UNED) participate, questions this hypothesis.
"It is improbable that the last Neanderthals of central and southern Iberia would have persisted until such a late date, approximately 30,000 years ago, as ...
Mutations in ASXL3 cause problems similar to Bohring-Opitz syndrome
2013-02-05
Mutations which affect the gene ASXL3 cause a novel syndrome similar to Bohring-Opitz syndrome, finds a study published in BioMed Central's open access journal Genome Medicine. This molecular definition distinguishes these children from those with Bohring-Opitz, and other similar syndromes, and highlights a technique able to help define rare diseases.
When Dr Ropers from the Max-Planck Institute for Molecular Genetics in Berlin found a child with non-specific symptoms, including small size at birth, difficulties with movement and feeding, severe intellectual disability, ...
Researchers pioneer treatment for viral infection common in children
2013-02-05
Researchers at Imperial College London have discovered a new way in which a very common childhood disease could be treated.
In the first year of life, 65 per cent of babies get infected by Respiratory Syncytial Virus (RSV). This causes bronchiolitis, and is thought to kill nearly 200,000 children every year worldwide.
In 1966 and 1967, vaccines were tested for RSV. These had disastrous effects on the immune response, leading to a worsening of the disease and, in many cases, death. Scientists have so far not been able to fully explain this effect, which continues to ...
Could the humble sea urchin hold the key to carbon capture?
2013-02-05
A chance discovery that sea urchins use Nickel ions to harness carbon dioxide from the sea to grow their exoskeleton could be the key to capturing tonnes of CO2 from the atmosphere.
Experts at Newcastle University, UK, have discovered that in the presence of a Nickel catalyst, CO2 can be converted rapidly and cheaply into the harmless, solid mineral, calcium or magnesium carbonate.
This discovery, which is published today in the academic journal Catalysis Science & Technology, has the potential to revolutionise the way we capture and store carbon enabling us to significantly ...
Study examines potential transmission of AD, Parkinson's disease protein in cadaver hGH
2013-02-05
A group of recipients of cadaver-derived human growth hormone (c-hGH) does not appear to be at increased risk for Alzheimer and Parkinson disease despite their likely exposure to neurodegenerative disease (ND)-associated proteins and elevated risk of infectious prion protein-related disease, according to a report published Online First by JAMA Neurology, a JAMA Network publication.
David J. Irwin, M.D., of the University of Pennsylvania Perelman School of Medicine, Philadelphia, and colleagues looked for evidence for human-to-human transmission of Alzheimer disease (AD), ...
Study suggests glucagon-like peptide-1 receptor agonists related to adolescent weight loss
2013-02-05
Preliminary evidence from a clinical trial suggests that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
GLP-1 receptor agonist therapy, approved for adults with type 2 diabetes mellitus, reduces body weight by enhancing satiety and suppressing appetite, even in patients without diabetes, according to the study background.
Aaron S. Kelly, Ph.D., of the University ...
Around 1 in 10 young mentally ill teens drinks, smokes, and uses cannabis
2013-02-05
[Frequent alcohol, nicotine, or cannabis use is common in young persons presenting for mental healthcare: a cross sectional study doi 10.1136/bmjopen-2012-002229]
Around one in 10 young teens with mental health issues also drinks alcohol, smokes cigarettes, and uses cannabis on a weekly basis, indicates Australian research published in the online only fully journal BMJ Open.
The prevalence of this pattern of substance use increased with age, the study found, prompting the authors to raise concerns that these behaviours are likely to worsen both mental and physical ...
Sunlight may help ward off rheumatoid arthritis in women
2013-02-05
[Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses' Health Study Online First doi 10.1136/annrheumdis-2012-202302]
Regular exposure to sunlight—specifically ultraviolet B (UVB)—may reduce the risk of developing rheumatoid arthritis, indicates a large long term study published online in the Annals of the Rheumatic Diseases.
But the effect of UVB exposure was only evident among older women, possibly because younger women are more aware of the hazards of sunlight and so cover up with sun block, suggest the authors.
They ...